�ݺ�ߣshows by User: RajeshBendre

�ݺ�ߣshows by User: RajeshBendre / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: RajeshBendre / Thu, 28 Jan 2021 11:21:38 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: RajeshBendre Myositis review of autoantibody /slideshow/myositis-review-of-autoantibody/241953792 myositisreviewofautoantibody-210128112138
Diagnosing PM/DM is challenging due to rarity of the disease, their similar clinical presentation and the possibility of overlap syndromes. A comprehensive strategy for serological testing comprises of parallel determination of both MSA and MAA thereby reducing the time to diagnosis. Current immunoassays techniques (Immunoblot) targeting MAA & MSAs have – The ability to include many parameters simultaneously which ensures higher detection rate; Become readily accessible & hence an opportunity for laboratories to contribute significantly in the disease diagnosis. MSA are highly specific for PM/DM, and many of them are also associated with a unique clinical subset of PM/DM, making them useful clinical diagnostic/prognostic biomarkers & continue to evolve.]]>
Diagnosing PM/DM is challenging due to rarity of the disease, their similar clinical presentation and the possibility of overlap syndromes. A comprehensive strategy for serological testing comprises of parallel determination of both MSA and MAA thereby reducing the time to diagnosis. Current immunoassays techniques (Immunoblot) targeting MAA & MSAs have – The ability to include many parameters simultaneously which ensures higher detection rate; Become readily accessible & hence an opportunity for laboratories to contribute significantly in the disease diagnosis. MSA are highly specific for PM/DM, and many of them are also associated with a unique clinical subset of PM/DM, making them useful clinical diagnostic/prognostic biomarkers & continue to evolve.]]> Thu, 28 Jan 2021 11:21:38 GMT /slideshow/myositis-review-of-autoantibody/241953792 RajeshBendre@slideshare.net(RajeshBendre) Myositis review of autoantibody RajeshBendre Diagnosing PM/DM is challenging due to rarity of the disease, their similar clinical presentation and the possibility of overlap syndromes. A comprehensive strategy for serological testing comprises of parallel determination of both MSA and MAA thereby reducing the time to diagnosis. Current immunoassays techniques (Immunoblot) targeting MAA & MSAs have – The ability to include many parameters simultaneously which ensures higher detection rate; Become readily accessible & hence an opportunity for laboratories to contribute significantly in the disease diagnosis. MSA are highly specific for PM/DM, and many of them are also associated with a unique clinical subset of PM/DM, making them useful clinical diagnostic/prognostic biomarkers & continue to evolve. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/myositisreviewofautoantibody-210128112138-thumbnail.jpg?width=120&height=120&fit=bounds" /> Diagnosing PM/DM is challenging due to rarity of the disease, their similar clinical presentation and the possibility of overlap syndromes. A comprehensive strategy for serological testing comprises of parallel determination of both MSA and MAA thereby reducing the time to diagnosis. Current immunoassays techniques (Immunoblot) targeting MAA & MSAs have – The ability to include many parameters simultaneously which ensures higher detection rate; Become readily accessible & hence an opportunity for laboratories to contribute significantly in the disease diagnosis. MSA are highly specific for PM/DM, and many of them are also associated with a unique clinical subset of PM/DM, making them useful clinical diagnostic/prognostic biomarkers & continue to evolve.

Myositis review of autoantibody from Dr. Rajesh Bendre

]]> 940 0 https://cdn.slidesharecdn.com/ss_thumbnails/myositisreviewofautoantibody-210128112138-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Interpretative Lab reports /slideshow/interpretative-lab-reports/205746836 interpretativelabreports-191214094958
Interpretative lab reports having test specific comments & notes is becoming a need & tool for clinical interface. Various quality guidelines have also included interpretative & advisory services as part of checklist & scope for laboratory accreditation. However, every laboratory needs to strategize methodology along with its LIMS, ways for implementation.]]>
Interpretative lab reports having test specific comments & notes is becoming a need & tool for clinical interface. Various quality guidelines have also included interpretative & advisory services as part of checklist & scope for laboratory accreditation. However, every laboratory needs to strategize methodology along with its LIMS, ways for implementation.]]> Sat, 14 Dec 2019 09:49:58 GMT /slideshow/interpretative-lab-reports/205746836 RajeshBendre@slideshare.net(RajeshBendre) Interpretative Lab reports RajeshBendre Interpretative lab reports having test specific comments & notes is becoming a need & tool for clinical interface. Various quality guidelines have also included interpretative & advisory services as part of checklist & scope for laboratory accreditation. However, every laboratory needs to strategize methodology along with its LIMS, ways for implementation. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/interpretativelabreports-191214094958-thumbnail.jpg?width=120&height=120&fit=bounds" /> Interpretative lab reports having test specific comments & notes is becoming a need & tool for clinical interface. Various quality guidelines have also included interpretative & advisory services as part of checklist & scope for laboratory accreditation. However, every laboratory needs to strategize methodology along with its LIMS, ways for implementation.

Interpretative Lab reports from Dr. Rajesh Bendre

]]> 2394 6 https://cdn.slidesharecdn.com/ss_thumbnails/interpretativelabreports-191214094958-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Blood components tranfusion guidelines update /slideshow/blood-components-tranfusion-guidelines-update/191971310 bloodcomponentstranfusionguidelines-update-191110104053
Transfusion Medicine has evolved in last decade & many societies have given recommendations for safe transfusion practices. Compiling these recommendations is very useful academic & practical activity]]>
Transfusion Medicine has evolved in last decade & many societies have given recommendations for safe transfusion practices. Compiling these recommendations is very useful academic & practical activity]]> Sun, 10 Nov 2019 10:40:53 GMT /slideshow/blood-components-tranfusion-guidelines-update/191971310 RajeshBendre@slideshare.net(RajeshBendre) Blood components tranfusion guidelines update RajeshBendre Transfusion Medicine has evolved in last decade & many societies have given recommendations for safe transfusion practices. Compiling these recommendations is very useful academic & practical activity <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/bloodcomponentstranfusionguidelines-update-191110104053-thumbnail.jpg?width=120&height=120&fit=bounds" /> Transfusion Medicine has evolved in last decade & many societies have given recommendations for safe transfusion practices. Compiling these recommendations is very useful academic & practical activity

Blood components tranfusion guidelines update from Dr. Rajesh Bendre

]]> 2817 2 https://cdn.slidesharecdn.com/ss_thumbnails/bloodcomponentstranfusionguidelines-update-191110104053-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Cardiac biomarker- Update /slideshow/cardiac-biomarker-update/177759236 cardiacbiomarker-190930140907
Cardiac biomarkers have evolved over last 20 years. From enzymes like CPK,SGOT,LDH, the focus shifted to CPKMB mass & currently to high sensitive Troponins. Similarly the definition of AMI also evolved and included these markers in guidelines. Natriuretic peptides (BNP & Nt-proBNP) are good markers for heart failure. however, ACS in renal failure continues to have diagnostic challenges.]]>
Cardiac biomarkers have evolved over last 20 years. From enzymes like CPK,SGOT,LDH, the focus shifted to CPKMB mass & currently to high sensitive Troponins. Similarly the definition of AMI also evolved and included these markers in guidelines. Natriuretic peptides (BNP & Nt-proBNP) are good markers for heart failure. however, ACS in renal failure continues to have diagnostic challenges.]]> Mon, 30 Sep 2019 14:09:07 GMT /slideshow/cardiac-biomarker-update/177759236 RajeshBendre@slideshare.net(RajeshBendre) Cardiac biomarker- Update RajeshBendre Cardiac biomarkers have evolved over last 20 years. From enzymes like CPK,SGOT,LDH, the focus shifted to CPKMB mass & currently to high sensitive Troponins. Similarly the definition of AMI also evolved and included these markers in guidelines. Natriuretic peptides (BNP & Nt-proBNP) are good markers for heart failure. however, ACS in renal failure continues to have diagnostic challenges. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/cardiacbiomarker-190930140907-thumbnail.jpg?width=120&height=120&fit=bounds" /> Cardiac biomarkers have evolved over last 20 years. From enzymes like CPK,SGOT,LDH, the focus shifted to CPKMB mass & currently to high sensitive Troponins. Similarly the definition of AMI also evolved and included these markers in guidelines. Natriuretic peptides (BNP & Nt-proBNP) are good markers for heart failure. however, ACS in renal failure continues to have diagnostic challenges.

Cardiac biomarker- Update from Dr. Rajesh Bendre

]]> 812 1 https://cdn.slidesharecdn.com/ss_thumbnails/cardiacbiomarker-190930140907-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Immunoassay basic concepts for clinical pathologist /slideshow/immunoassay-basic-concepts-for-clinical-pathologist/175981117 immunoassay-basicconceptsforclinicalpathologist-190925135003
Immunoassays as technique have evolved considerably since the invention of Radioimmunoassay, monoclonal antibody, Recombinant technology & successfully achieved automation. However, many of the hormonal assays still lack standardization and/or Harmonization resulting in significant variability in test results. Using alternate methods, adopting procedures for sample pre-treatment, serial dilution of sample are some of the ways to troubleshoot these discrepant result]]>
Immunoassays as technique have evolved considerably since the invention of Radioimmunoassay, monoclonal antibody, Recombinant technology & successfully achieved automation. However, many of the hormonal assays still lack standardization and/or Harmonization resulting in significant variability in test results. Using alternate methods, adopting procedures for sample pre-treatment, serial dilution of sample are some of the ways to troubleshoot these discrepant result]]> Wed, 25 Sep 2019 13:50:03 GMT /slideshow/immunoassay-basic-concepts-for-clinical-pathologist/175981117 RajeshBendre@slideshare.net(RajeshBendre) Immunoassay basic concepts for clinical pathologist RajeshBendre Immunoassays as technique have evolved considerably since the invention of Radioimmunoassay, monoclonal antibody, Recombinant technology & successfully achieved automation. However, many of the hormonal assays still lack standardization and/or Harmonization resulting in significant variability in test results. Using alternate methods, adopting procedures for sample pre-treatment, serial dilution of sample are some of the ways to troubleshoot these discrepant result <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/immunoassay-basicconceptsforclinicalpathologist-190925135003-thumbnail.jpg?width=120&height=120&fit=bounds" /> Immunoassays as technique have evolved considerably since the invention of Radioimmunoassay, monoclonal antibody, Recombinant technology & successfully achieved automation. However, many of the hormonal assays still lack standardization and/or Harmonization resulting in significant variability in test results. Using alternate methods, adopting procedures for sample pre-treatment, serial dilution of sample are some of the ways to troubleshoot these discrepant result

Immunoassay basic concepts for clinical pathologist from Dr. Rajesh Bendre

]]> 2305 7 https://cdn.slidesharecdn.com/ss_thumbnails/immunoassay-basicconceptsforclinicalpathologist-190925135003-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Body fluid interpretation /slideshow/body-fluid-interpretation/165474804 bodyfluidinterpretation-190822013458
Body Fluid reporting & interpretation has many inherent challenges right from sample collection, selection of tests, test method validation, appropriate reference intervals & clinical decision limits. Recent published articles & guidelines clarify most of the above mentioned concerns for all laboratory to adopt & implement.]]>
Body Fluid reporting & interpretation has many inherent challenges right from sample collection, selection of tests, test method validation, appropriate reference intervals & clinical decision limits. Recent published articles & guidelines clarify most of the above mentioned concerns for all laboratory to adopt & implement.]]> Thu, 22 Aug 2019 01:34:58 GMT /slideshow/body-fluid-interpretation/165474804 RajeshBendre@slideshare.net(RajeshBendre) Body fluid interpretation RajeshBendre Body Fluid reporting & interpretation has many inherent challenges right from sample collection, selection of tests, test method validation, appropriate reference intervals & clinical decision limits. Recent published articles & guidelines clarify most of the above mentioned concerns for all laboratory to adopt & implement. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/bodyfluidinterpretation-190822013458-thumbnail.jpg?width=120&height=120&fit=bounds" /> Body Fluid reporting & interpretation has many inherent challenges right from sample collection, selection of tests, test method validation, appropriate reference intervals & clinical decision limits. Recent published articles & guidelines clarify most of the above mentioned concerns for all laboratory to adopt & implement.

Body fluid interpretation from Dr. Rajesh Bendre

]]> 1308 3 https://cdn.slidesharecdn.com/ss_thumbnails/bodyfluidinterpretation-190822013458-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Preanalytical quality control practices in clinical laboratory /slideshow/preanalytical-quality-control-practices-in-clinical-laboratory/156659781 preanalyticalqualitycontrolpracticesinclinicallaboratory-190720150006
Preanalytical variables contribute maximally to lab errors. However, these variables are most difficult to control as they include human dependency for phlebotomy skills & pretest patient conditioning. Quantifying & monitoring these variables is also more challenging. Use of checklists, continuous training, competency assessments, internal audits & clinician education for appropriate test utilization form some of the tools for improving the preanalytical processes.]]>
Preanalytical variables contribute maximally to lab errors. However, these variables are most difficult to control as they include human dependency for phlebotomy skills & pretest patient conditioning. Quantifying & monitoring these variables is also more challenging. Use of checklists, continuous training, competency assessments, internal audits & clinician education for appropriate test utilization form some of the tools for improving the preanalytical processes.]]> Sat, 20 Jul 2019 15:00:06 GMT /slideshow/preanalytical-quality-control-practices-in-clinical-laboratory/156659781 RajeshBendre@slideshare.net(RajeshBendre) Preanalytical quality control practices in clinical laboratory RajeshBendre Preanalytical variables contribute maximally to lab errors. However, these variables are most difficult to control as they include human dependency for phlebotomy skills & pretest patient conditioning. Quantifying & monitoring these variables is also more challenging. Use of checklists, continuous training, competency assessments, internal audits & clinician education for appropriate test utilization form some of the tools for improving the preanalytical processes. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/preanalyticalqualitycontrolpracticesinclinicallaboratory-190720150006-thumbnail.jpg?width=120&height=120&fit=bounds" /> Preanalytical variables contribute maximally to lab errors. However, these variables are most difficult to control as they include human dependency for phlebotomy skills & pretest patient conditioning. Quantifying & monitoring these variables is also more challenging. Use of checklists, continuous training, competency assessments, internal audits & clinician education for appropriate test utilization form some of the tools for improving the preanalytical processes.

Preanalytical quality control practices in clinical laboratory from Dr. Rajesh Bendre

]]> 6352 6 https://cdn.slidesharecdn.com/ss_thumbnails/preanalyticalqualitycontrolpracticesinclinicallaboratory-190720150006-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Anti-Mullerian Hormone (AMH) -Novel Biomarker & its Applications /slideshow/antimullerian-hormone-amh-novel-biomarker-its-applications/152901288 amhapplications-190701080153
Serum anti-Mullerian hormone (AMH) is a unique biomarker that has a critical role in folliculogenesis as well as steroidogenesis within ovaries. Secretion from preantral and early antral follicles renders AMH as the earliest marker to show ovarian reserve decline. ]]>
Serum anti-Mullerian hormone (AMH) is a unique biomarker that has a critical role in folliculogenesis as well as steroidogenesis within ovaries. Secretion from preantral and early antral follicles renders AMH as the earliest marker to show ovarian reserve decline. ]]> Mon, 01 Jul 2019 08:01:53 GMT /slideshow/antimullerian-hormone-amh-novel-biomarker-its-applications/152901288 RajeshBendre@slideshare.net(RajeshBendre) Anti-Mullerian Hormone (AMH) -Novel Biomarker & its Applications RajeshBendre Serum anti-Mullerian hormone (AMH) is a unique biomarker that has a critical role in folliculogenesis as well as steroidogenesis within ovaries. Secretion from preantral and early antral follicles renders AMH as the earliest marker to show ovarian reserve decline. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/amhapplications-190701080153-thumbnail.jpg?width=120&height=120&fit=bounds" /> Serum anti-Mullerian hormone (AMH) is a unique biomarker that has a critical role in folliculogenesis as well as steroidogenesis within ovaries. Secretion from preantral and early antral follicles renders AMH as the earliest marker to show ovarian reserve decline.

Anti-Mullerian Hormone (AMH) -Novel Biomarker & its Applications from Dr. Rajesh Bendre

]]> 3272 3 https://cdn.slidesharecdn.com/ss_thumbnails/amhapplications-190701080153-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Interpreting Abnormal hemoglobin study /slideshow/interpreting-abnormal-hemoglobin-study/135629293 interpretinghemoglobinopathy-190311133352
challenges in interpreting abnormal hemoglobin study- the key is to correlate with patient age, ethnicity,RBC indices & morphology findings. Two tier approach for correct characterization of abnormal hemoglobins of HPLC &/or capillary electrophoresis.]]>
challenges in interpreting abnormal hemoglobin study- the key is to correlate with patient age, ethnicity,RBC indices & morphology findings. Two tier approach for correct characterization of abnormal hemoglobins of HPLC &/or capillary electrophoresis.]]> Mon, 11 Mar 2019 13:33:52 GMT /slideshow/interpreting-abnormal-hemoglobin-study/135629293 RajeshBendre@slideshare.net(RajeshBendre) Interpreting Abnormal hemoglobin study RajeshBendre challenges in interpreting abnormal hemoglobin study- the key is to correlate with patient age, ethnicity,RBC indices & morphology findings. Two tier approach for correct characterization of abnormal hemoglobins of HPLC &/or capillary electrophoresis. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/interpretinghemoglobinopathy-190311133352-thumbnail.jpg?width=120&height=120&fit=bounds" /> challenges in interpreting abnormal hemoglobin study- the key is to correlate with patient age, ethnicity,RBC indices & morphology findings. Two tier approach for correct characterization of abnormal hemoglobins of HPLC &/or capillary electrophoresis.

Interpreting Abnormal hemoglobin study from Dr. Rajesh Bendre

]]> 24563 6 https://cdn.slidesharecdn.com/ss_thumbnails/interpretinghemoglobinopathy-190311133352-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Interpreting serum protein electrophoresis /slideshow/interpreting-serum-protein-electrophoresis/135629117 interpretingproteinelectrophoresis-190311133010
Challenges in interpreting serum protein electrophoresis. Requires an approach to recognize pattern within the various protein fractions & differentiate systemic inflammatory response from abnormal antibody production due to neoplastic disorders.Presence of M-band does not always correlate with plasma cell disorders but can be seen some lymphomas, chronic leukaemias, systemic amyloidosis hence need further ancillary tests for diagnosis of aetiology for the M-band.]]>
Challenges in interpreting serum protein electrophoresis. Requires an approach to recognize pattern within the various protein fractions & differentiate systemic inflammatory response from abnormal antibody production due to neoplastic disorders.Presence of M-band does not always correlate with plasma cell disorders but can be seen some lymphomas, chronic leukaemias, systemic amyloidosis hence need further ancillary tests for diagnosis of aetiology for the M-band.]]> Mon, 11 Mar 2019 13:30:10 GMT /slideshow/interpreting-serum-protein-electrophoresis/135629117 RajeshBendre@slideshare.net(RajeshBendre) Interpreting serum protein electrophoresis RajeshBendre Challenges in interpreting serum protein electrophoresis. Requires an approach to recognize pattern within the various protein fractions & differentiate systemic inflammatory response from abnormal antibody production due to neoplastic disorders.Presence of M-band does not always correlate with plasma cell disorders but can be seen some lymphomas, chronic leukaemias, systemic amyloidosis hence need further ancillary tests for diagnosis of aetiology for the M-band. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/interpretingproteinelectrophoresis-190311133010-thumbnail.jpg?width=120&height=120&fit=bounds" /> Challenges in interpreting serum protein electrophoresis. Requires an approach to recognize pattern within the various protein fractions & differentiate systemic inflammatory response from abnormal antibody production due to neoplastic disorders.Presence of M-band does not always correlate with plasma cell disorders but can be seen some lymphomas, chronic leukaemias, systemic amyloidosis hence need further ancillary tests for diagnosis of aetiology for the M-band.

Interpreting serum protein electrophoresis from Dr. Rajesh Bendre

]]> 24834 4 https://cdn.slidesharecdn.com/ss_thumbnails/interpretingproteinelectrophoresis-190311133010-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Maternal screening for fetal Aneuploidy- Update on Laboratory Tests /slideshow/maternal-screening-update-on-laboratory-tests/133862955 maternalscreening-190301145423
Maternal screening for aneuploidy disorders using maternal serum hormonal immunossay levels & statistical risk algorithm is recommended to be used as a universal process as per ACOG & SOGC. Maternal blood has circulating fetal DNA which can be targeted in screening molecular tests like Non-Invasive prenatal testing(NIPT) for identifying aneuploidy. However, confirmatory tests still are cytogenetics (karyotyping) based tests using sample from amniocentesis or CVS.]]>
Maternal screening for aneuploidy disorders using maternal serum hormonal immunossay levels & statistical risk algorithm is recommended to be used as a universal process as per ACOG & SOGC. Maternal blood has circulating fetal DNA which can be targeted in screening molecular tests like Non-Invasive prenatal testing(NIPT) for identifying aneuploidy. However, confirmatory tests still are cytogenetics (karyotyping) based tests using sample from amniocentesis or CVS.]]> Fri, 01 Mar 2019 14:54:23 GMT /slideshow/maternal-screening-update-on-laboratory-tests/133862955 RajeshBendre@slideshare.net(RajeshBendre) Maternal screening for fetal Aneuploidy- Update on Laboratory Tests RajeshBendre Maternal screening for aneuploidy disorders using maternal serum hormonal immunossay levels & statistical risk algorithm is recommended to be used as a universal process as per ACOG & SOGC. Maternal blood has circulating fetal DNA which can be targeted in screening molecular tests like Non-Invasive prenatal testing(NIPT) for identifying aneuploidy. However, confirmatory tests still are cytogenetics (karyotyping) based tests using sample from amniocentesis or CVS. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/maternalscreening-190301145423-thumbnail.jpg?width=120&height=120&fit=bounds" /> Maternal screening for aneuploidy disorders using maternal serum hormonal immunossay levels & statistical risk algorithm is recommended to be used as a universal process as per ACOG & SOGC. Maternal blood has circulating fetal DNA which can be targeted in screening molecular tests like Non-Invasive prenatal testing(NIPT) for identifying aneuploidy. However, confirmatory tests still are cytogenetics (karyotyping) based tests using sample from amniocentesis or CVS.

Maternal screening for fetal Aneuploidy- Update on Laboratory Tests from Dr. Rajesh Bendre

]]> 487 3 https://cdn.slidesharecdn.com/ss_thumbnails/maternalscreening-190301145423-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Coagulation disorders laboratory diagnostic pitfalls /slideshow/coagulation-disorders-laboratory-diagnostic-pitfalls/133787616 coagulationdisorders-laboratorydiagnosticpitfalls-190301013319
Common Diagnostic pitfalls with coagulation disorders lies in addressing challenges in preanalytical processes & implementation of algorithms as per newer guidelines.]]>
Common Diagnostic pitfalls with coagulation disorders lies in addressing challenges in preanalytical processes & implementation of algorithms as per newer guidelines.]]> Fri, 01 Mar 2019 01:33:19 GMT /slideshow/coagulation-disorders-laboratory-diagnostic-pitfalls/133787616 RajeshBendre@slideshare.net(RajeshBendre) Coagulation disorders laboratory diagnostic pitfalls RajeshBendre Common Diagnostic pitfalls with coagulation disorders lies in addressing challenges in preanalytical processes & implementation of algorithms as per newer guidelines. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/coagulationdisorders-laboratorydiagnosticpitfalls-190301013319-thumbnail.jpg?width=120&height=120&fit=bounds" /> Common Diagnostic pitfalls with coagulation disorders lies in addressing challenges in preanalytical processes & implementation of algorithms as per newer guidelines.

Coagulation disorders laboratory diagnostic pitfalls from Dr. Rajesh Bendre

]]> 565 5 https://cdn.slidesharecdn.com/ss_thumbnails/coagulationdisorders-laboratorydiagnosticpitfalls-190301013319-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Immunosuppressant drugs tdm laboratory perspective /slideshow/immunosuppressant-drugs-tdm-laboratory-perspective/133096787 immunosuppressantdrugstdmlaboratoryperspective-190224133215
Laboratory offering TDM for Immunosuppressive Drugs needs to understands their pharmacodynamics & clinical applications so that the results value add in the patient care]]>
Laboratory offering TDM for Immunosuppressive Drugs needs to understands their pharmacodynamics & clinical applications so that the results value add in the patient care]]> Sun, 24 Feb 2019 13:32:15 GMT /slideshow/immunosuppressant-drugs-tdm-laboratory-perspective/133096787 RajeshBendre@slideshare.net(RajeshBendre) Immunosuppressant drugs tdm laboratory perspective RajeshBendre Laboratory offering TDM for Immunosuppressive Drugs needs to understands their pharmacodynamics & clinical applications so that the results value add in the patient care <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/immunosuppressantdrugstdmlaboratoryperspective-190224133215-thumbnail.jpg?width=120&height=120&fit=bounds" /> Laboratory offering TDM for Immunosuppressive Drugs needs to understands their pharmacodynamics & clinical applications so that the results value add in the patient care

Immunosuppressant drugs tdm laboratory perspective from Dr. Rajesh Bendre

]]> 1713 3 https://cdn.slidesharecdn.com/ss_thumbnails/immunosuppressantdrugstdmlaboratoryperspective-190224133215-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Autoimmune liver disease laboratory diagnosis /slideshow/autoimmune-liver-disease-laboratory-diagnosis/133095450 autoimmuneliverdisease-laboratorydiagnosis-190224130434
Autoimmune liver disease is a heterogenous group of disorders. Laboratory diagnosis plays an important role in early diagnosis. Availability of transfected cells(F-Actin HEK cells) & cell based assays have increased the test specificity significantly.]]>
Autoimmune liver disease is a heterogenous group of disorders. Laboratory diagnosis plays an important role in early diagnosis. Availability of transfected cells(F-Actin HEK cells) & cell based assays have increased the test specificity significantly.]]> Sun, 24 Feb 2019 13:04:34 GMT /slideshow/autoimmune-liver-disease-laboratory-diagnosis/133095450 RajeshBendre@slideshare.net(RajeshBendre) Autoimmune liver disease laboratory diagnosis RajeshBendre Autoimmune liver disease is a heterogenous group of disorders. Laboratory diagnosis plays an important role in early diagnosis. Availability of transfected cells(F-Actin HEK cells) & cell based assays have increased the test specificity significantly. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/autoimmuneliverdisease-laboratorydiagnosis-190224130434-thumbnail.jpg?width=120&height=120&fit=bounds" /> Autoimmune liver disease is a heterogenous group of disorders. Laboratory diagnosis plays an important role in early diagnosis. Availability of transfected cells(F-Actin HEK cells) & cell based assays have increased the test specificity significantly.

Autoimmune liver disease laboratory diagnosis from Dr. Rajesh Bendre

]]> 1552 5 https://cdn.slidesharecdn.com/ss_thumbnails/autoimmuneliverdisease-laboratorydiagnosis-190224130434-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Biomarker for inflammatory bowel disease(IBD) /slideshow/biomarker-for-inflammatory-bowel-diseaseibd/133094551 biomarkerforinflammatoryboweldiseaseibd-190224124751
Diagnosis of Inflammatory bowel disease have challenges including differentiating from Irritable bowel disease using noninvasive biomarkers. Fecal calprotectin is a novel fecal marker which meets the diagnostic & monitoring requirements for IBD.]]>
Diagnosis of Inflammatory bowel disease have challenges including differentiating from Irritable bowel disease using noninvasive biomarkers. Fecal calprotectin is a novel fecal marker which meets the diagnostic & monitoring requirements for IBD.]]> Sun, 24 Feb 2019 12:47:51 GMT /slideshow/biomarker-for-inflammatory-bowel-diseaseibd/133094551 RajeshBendre@slideshare.net(RajeshBendre) Biomarker for inflammatory bowel disease(IBD) RajeshBendre Diagnosis of Inflammatory bowel disease have challenges including differentiating from Irritable bowel disease using noninvasive biomarkers. Fecal calprotectin is a novel fecal marker which meets the diagnostic & monitoring requirements for IBD. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/biomarkerforinflammatoryboweldiseaseibd-190224124751-thumbnail.jpg?width=120&height=120&fit=bounds" /> Diagnosis of Inflammatory bowel disease have challenges including differentiating from Irritable bowel disease using noninvasive biomarkers. Fecal calprotectin is a novel fecal marker which meets the diagnostic & monitoring requirements for IBD.

Biomarker for inflammatory bowel disease(IBD) from Dr. Rajesh Bendre

]]> 1999 3 https://cdn.slidesharecdn.com/ss_thumbnails/biomarkerforinflammatoryboweldiseaseibd-190224124751-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Chronic renal failure update on diagnostic tests /slideshow/chrocin-renal-failure-update-on-diagnostic-tests/133093648 chrocinrenalfailureupdateondiagnostictests-190224122750
Diagnostic & monitoring tests for CRF as eGFR, Microalbuminuria & Reticulocyte hemoglobin (for identifying functional Iron deficiency) are important.]]>
Diagnostic & monitoring tests for CRF as eGFR, Microalbuminuria & Reticulocyte hemoglobin (for identifying functional Iron deficiency) are important.]]> Sun, 24 Feb 2019 12:27:50 GMT /slideshow/chrocin-renal-failure-update-on-diagnostic-tests/133093648 RajeshBendre@slideshare.net(RajeshBendre) Chronic renal failure update on diagnostic tests RajeshBendre Diagnostic & monitoring tests for CRF as eGFR, Microalbuminuria & Reticulocyte hemoglobin (for identifying functional Iron deficiency) are important. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/chrocinrenalfailureupdateondiagnostictests-190224122750-thumbnail.jpg?width=120&height=120&fit=bounds" /> Diagnostic & monitoring tests for CRF as eGFR, Microalbuminuria & Reticulocyte hemoglobin (for identifying functional Iron deficiency) are important.

Chronic renal failure update on diagnostic tests from Dr. Rajesh Bendre

]]> 1586 5 https://cdn.slidesharecdn.com/ss_thumbnails/chrocinrenalfailureupdateondiagnostictests-190224122750-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Clinical laboratory quality audit aligning ISO15189 2012 /RajeshBendre/clinical-laboratory-quality-audit-aligning-iso15189-2012 clinicallaboratoryqualityauditaligningiso15189-2012-190224062712
Aligning & implementation of ISO15189:2012 requirements in clinical laboratory includes enlisting & mapping the exact activities to be performed with each clause, having done the same it acts as a road map for monitoring & continuous improvement ]]>
Aligning & implementation of ISO15189:2012 requirements in clinical laboratory includes enlisting & mapping the exact activities to be performed with each clause, having done the same it acts as a road map for monitoring & continuous improvement ]]> Sun, 24 Feb 2019 06:27:12 GMT /RajeshBendre/clinical-laboratory-quality-audit-aligning-iso15189-2012 RajeshBendre@slideshare.net(RajeshBendre) Clinical laboratory quality audit aligning ISO15189 2012 RajeshBendre Aligning & implementation of ISO15189:2012 requirements in clinical laboratory includes enlisting & mapping the exact activities to be performed with each clause, having done the same it acts as a road map for monitoring & continuous improvement <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/clinicallaboratoryqualityauditaligningiso15189-2012-190224062712-thumbnail.jpg?width=120&height=120&fit=bounds" /> Aligning & implementation of ISO15189:2012 requirements in clinical laboratory includes enlisting & mapping the exact activities to be performed with each clause, having done the same it acts as a road map for monitoring & continuous improvement

Clinical laboratory quality audit aligning ISO15189 2012 from Dr. Rajesh Bendre

]]> 1033 4 https://cdn.slidesharecdn.com/ss_thumbnails/clinicallaboratoryqualityauditaligningiso15189-2012-190224062712-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Controlling clinical laboratory errors /slideshow/controlling-clinical-laboratory-errors/133069895 controllingclinicallaboratoryerrors-190224033354
In the continuous quality journey, Controlling laboratory Errors is an integral part & focusing on analytical, post-analytical process is the first step. Developing a reporting culture followed by thorough analysis and implementation of appropriate corrective, preventive actions is required.]]>
In the continuous quality journey, Controlling laboratory Errors is an integral part & focusing on analytical, post-analytical process is the first step. Developing a reporting culture followed by thorough analysis and implementation of appropriate corrective, preventive actions is required.]]> Sun, 24 Feb 2019 03:33:54 GMT /slideshow/controlling-clinical-laboratory-errors/133069895 RajeshBendre@slideshare.net(RajeshBendre) Controlling clinical laboratory errors RajeshBendre In the continuous quality journey, Controlling laboratory Errors is an integral part & focusing on analytical, post-analytical process is the first step. Developing a reporting culture followed by thorough analysis and implementation of appropriate corrective, preventive actions is required. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/controllingclinicallaboratoryerrors-190224033354-thumbnail.jpg?width=120&height=120&fit=bounds" /> In the continuous quality journey, Controlling laboratory Errors is an integral part & focusing on analytical, post-analytical process is the first step. Developing a reporting culture followed by thorough analysis and implementation of appropriate corrective, preventive actions is required.

Controlling clinical laboratory errors from Dr. Rajesh Bendre

]]> 7566 4 https://cdn.slidesharecdn.com/ss_thumbnails/controllingclinicallaboratoryerrors-190224033354-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Role of tumour markers in clinical practice /slideshow/role-of-tumour-markers-in-clinical-practice/132910162 roleoftumourmarkersinclinicalpractice-190222162853
Tumour Markers are substances present in the tumour, produced by the tumour or by the host as a response to the presence of the tumour, providing information about biological characteristics of the tumour. these tumour markers may specific for the tissue but often get elevated in neoplastic as well non-neoplastic lesions, further Various analytical platforms available for serum tumour markers lack standardisation. These factors add to interpretative challenges in serum tumour markers ]]>
Tumour Markers are substances present in the tumour, produced by the tumour or by the host as a response to the presence of the tumour, providing information about biological characteristics of the tumour. these tumour markers may specific for the tissue but often get elevated in neoplastic as well non-neoplastic lesions, further Various analytical platforms available for serum tumour markers lack standardisation. These factors add to interpretative challenges in serum tumour markers ]]> Fri, 22 Feb 2019 16:28:53 GMT /slideshow/role-of-tumour-markers-in-clinical-practice/132910162 RajeshBendre@slideshare.net(RajeshBendre) Role of tumour markers in clinical practice RajeshBendre Tumour Markers are substances present in the tumour, produced by the tumour or by the host as a response to the presence of the tumour, providing information about biological characteristics of the tumour. these tumour markers may specific for the tissue but often get elevated in neoplastic as well non-neoplastic lesions, further Various analytical platforms available for serum tumour markers lack standardisation. These factors add to interpretative challenges in serum tumour markers <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/roleoftumourmarkersinclinicalpractice-190222162853-thumbnail.jpg?width=120&height=120&fit=bounds" /> Tumour Markers are substances present in the tumour, produced by the tumour or by the host as a response to the presence of the tumour, providing information about biological characteristics of the tumour. these tumour markers may specific for the tissue but often get elevated in neoplastic as well non-neoplastic lesions, further Various analytical platforms available for serum tumour markers lack standardisation. These factors add to interpretative challenges in serum tumour markers

Role of tumour markers in clinical practice from Dr. Rajesh Bendre

]]> 2466 9 https://cdn.slidesharecdn.com/ss_thumbnails/roleoftumourmarkersinclinicalpractice-190222162853-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Laboratory Information Management System /slideshow/laboratory-information-management-system-132382661/132382661 lims-190219095352
Purpose of a LIMS is to improve lab efficiency and accuracy by reducing manual operations. A LIMS system will perform a range of core functions. These include - Workflow management, Record keeping, Inventory management, Reporting. There will be differences between various LIMS systems, such as mobile-access, customization options and the level of technical support provided.]]>
Purpose of a LIMS is to improve lab efficiency and accuracy by reducing manual operations. A LIMS system will perform a range of core functions. These include - Workflow management, Record keeping, Inventory management, Reporting. There will be differences between various LIMS systems, such as mobile-access, customization options and the level of technical support provided.]]> Tue, 19 Feb 2019 09:53:51 GMT /slideshow/laboratory-information-management-system-132382661/132382661 RajeshBendre@slideshare.net(RajeshBendre) Laboratory Information Management System RajeshBendre Purpose of a LIMS is to improve lab efficiency and accuracy by reducing manual operations. A LIMS system will perform a range of core functions. These include - Workflow management, Record keeping, Inventory management, Reporting. There will be differences between various LIMS systems, such as mobile-access, customization options and the level of technical support provided. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/lims-190219095352-thumbnail.jpg?width=120&height=120&fit=bounds" /> Purpose of a LIMS is to improve lab efficiency and accuracy by reducing manual operations. A LIMS system will perform a range of core functions. These include - Workflow management, Record keeping, Inventory management, Reporting. There will be differences between various LIMS systems, such as mobile-access, customization options and the level of technical support provided.

Laboratory Information Management System from Dr. Rajesh Bendre

]]> 16513 7 https://cdn.slidesharecdn.com/ss_thumbnails/lims-190219095352-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://cdn.slidesharecdn.com/profile-photo-RajeshBendre-48x48.jpg?cb=1673234073 Technical Experience of 20+ years in Clinical Chemistry, Immunology, Hematopathology & Molecular pathology. Accomplished NABL, CAP Assessor as per ISO 15189:2012, Special Interest in Autoimmunity, Flow Cytometry, Hormonal, Drugs & Metal testing by HPLC, ICPMS, LCMS technologies, Molecular Diagnostic techniques for HLA, Infectious & Hemato-oncology biomarkers. Trained in Management of Component Blood Bank/Apheresis services. Certified for Laboratory Management, Team building through IIM-Kolkatta, IIM-Indore & Six Sigma Black Belt-Level I iACT. Acquired Skills in Development & Implementation of Laboratory Information System. About 10+ years of Academic Teaching experience for PG students https://cdn.slidesharecdn.com/ss_thumbnails/myositisreviewofautoantibody-210128112138-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/myositis-review-of-autoantibody/241953792 Myositis review of au... https://cdn.slidesharecdn.com/ss_thumbnails/interpretativelabreports-191214094958-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/interpretative-lab-reports/205746836 Interpretative Lab rep... https://cdn.slidesharecdn.com/ss_thumbnails/bloodcomponentstranfusionguidelines-update-191110104053-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/blood-components-tranfusion-guidelines-update/191971310 Blood components tranf...